カテゴリー： 世界, 医療/バイオ, IMARC

一塩基多型（SNP）ジェノタイピングのグローバル市場：TaqManSNPジェノタイピング、MassarraySNPジェノタイピング、SNP遺伝子チップアレイ、その他

【英語タイトル】Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (TaqMan SNP Genotyping, Massarray SNP Genotyping, SNP GeneChip Arrays, and Others), Application (Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology, and Others), and Region 2023-2028

IMARCが出版した調査資料（IMARC23JLY245）・商品コード：IMARC23JLY245
・発行会社（調査会社）：IMARC
・発行日：2023年7月
・ページ数：144
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

IMARC社の調査資料によると、2022年82.3億ドルであった世界の一塩基多型（SNP）ジェノタイピング市場規模が、予測期間中（2023年～2028年）年平均18.5％成長し、2028年には236億ドルに達すると予測されています。当書は、一塩基多型（SNP）ジェノタイピングの世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、技術別（TaqMan SNPジェノタイピング、Massarray SNPジェノタイピング、SNP遺伝子チップアレイ、その他）分析、用途別（動物遺伝学、植物改良、診断研究、医薬品＆ファーマコゲノミクス、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東/アフリカ）分析、推進要因・阻害要因・機会、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目がまとめられています。なお、当書に掲載されている企業情報には、Agilent Technologies Inc.、Eurofins Genomics (Eurofins Scientific SE)、Illumina Inc.、Integrated DNA Technologies、Inc. (Danaher Corporation)、LGC Limited、PREMIER Biosoft、Promega Corporation、QIAGEN N.V、Roche Holding AG、Thermo Fisher Scientific Inc.などが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の一塩基多型（SNP）ジェノタイピング市場規模：技術別
- TaqMan SNPジェノタイピング技術の市場規模
- Massarray SNPジェノタイピング技術の市場規模
- SNP遺伝子チップアレイ技術の市場規模
- その他技術の市場規模
・世界の一塩基多型（SNP）ジェノタイピング市場規模：用途別
- 動物遺伝学における市場規模
- 植物改良における市場規模
- 診断研究における市場規模
- 医薬品＆ファーマコゲノミクスにおける市場規模
- その他用途における市場規模
・世界の一塩基多型（SNP）ジェノタイピング市場規模：地域別
- 北米の一塩基多型（SNP）ジェノタイピング市場規模
- アジア太平洋の一塩基多型（SNP）ジェノタイピング市場規模
- ヨーロッパの一塩基多型（SNP）ジェノタイピング市場規模
- 中南米の一塩基多型（SNP）ジェノタイピング市場規模
- 中東/アフリカの一塩基多型（SNP）ジェノタイピング市場規模
・推進要因・阻害要因・機会
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

Market Overview:

The global single nucleotide polymorphism (SNP) genotyping market size reached US$ 8.23 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 23.6 Billion by 2028, exhibiting a growth rate (CAGR) of 18.5% during 2023-2028. The growing genotype research and development activities, rising demand for personalized medicine and novel drug delivery systems, and increasing demand for genetic analysis in animal and plant feedstock represent some of the key factors driving the market.

Single nucleotide polymorphism (SNP) genotyping is a technique designed to identify and analyze genetic variations among individuals by examining specific locations within their deoxyribonucleic acid (DNA) sequence. It involves determining the specific nucleotide present at a particular SNP site in the DNA of an individual. It relies on advanced molecular biology techniques, such as polymerase chain reaction (PCR) and DNA sequencing, wherein PCR amplifies the DNA segment containing the SNP, and then the nucleotide at the SNP site is determined either by directly sequencing the amplified DNA or using other methods like microarrays or allele-specific PCR. It aids in understanding population genetics, migration patterns, and evolutionary history. It plays a crucial role in determining response to medications, predicting disease susceptibility, and tailoring treatments to specific genetic profiles. SNP genotyping is used by researchers to study the genetic basis of complex diseases, identify genetic risk factors, and develop enhanced diagnostic tools.

Single Nucleotide Polymorphism (SNP) Genotyping Market Trends:
At present, the increasing demand for SNP genotyping on account of the rising genotype research and development activities and bioinformatics in the development of diagnostic tools or effective therapeutics for various diseases represents one of the crucial factors supporting the growth of the market. In addition, the growing utilization of SNP genotyping in the etiology of various human diseases, such as cancer, cardiovascular, Alzheimer’s, and asthma, is offering a favorable market outlook. Besides this, there is a rise in the demand for SNP genotyping to establish genetic relationships, resolve paternity disputes, and assist in criminal investigations around the world. This, along with the thriving medical industry, is propelling the growth of the market. Moreover, the increasing demand for pharmacogenomics due to the rising pipeline for personalized medicine and novel drug delivery systems is strengthening the growth of the market. Apart from this, numerous technologies of SNP genotyping in the life science field, such as agricultural biotechnology, diagnostic research, pharmaceuticals, pharmacogenomics, and animal and livestock breeding, are contributing to the growth of the market. In line with this, the growing prevalence of diabetes, cardiovascular diseases, and cancer across the globe is positively influencing the market. Furthermore, the rising demand for genetic analysis in animal and plant feedstock is bolstering the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global single nucleotide polymorphism (SNP) genotyping market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on technology and application.

Technology Insights:
TaqMan SNP Genotyping
Massarray SNP Genotyping
SNP GeneChip Arrays
Others

The report has provided a detailed breakup and analysis of the single nucleotide polymorphism (SNP) genotyping market based on the technology. This includes TaqMan SNP genotyping, massarray SNP genotyping, SNP GeneChip arrays, and others.

Application Insights:
Animal Genetics
Plant Improvement
Diagnostic Research
Pharmaceuticals and Pharmacogenomics
Agricultural Biotechnology
Others

A detailed breakup and analysis of the single nucleotide polymorphism (SNP) genotyping market based on the application has also been provided in the report. This includes animal genetics, plant improvement, diagnostic research, pharmaceuticals and pharmacogenomics, agricultural biotechnology, and others. According to the report, pharmaceuticals and pharmacogenomics accounted for the largest market share.

Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for single nucleotide polymorphism (SNP) genotyping. Some of the factors driving the North America single nucleotide polymorphism (SNP) genotyping market included favorable government policies towards proper diagnosis, increasing screening and treatment of fatal diseases, availability of enhanced research and development (R&D) facilities, etc.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global single nucleotide polymorphism (SNP) genotyping market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Eurofins Genomics (Eurofins Scientific SE), Illumina Inc., Integrated DNA Technologies, Inc. (Danaher Corporation), LGC Limited, PREMIER Biosoft, Promega Corporation, QIAGEN N.V, Roche Holding AG, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global single nucleotide polymorphism (SNP) genotyping market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global single nucleotide polymorphism (SNP) genotyping market?
What is the impact of each driver, restraint, and opportunity on the global single nucleotide polymorphism (SNP) genotyping market?
What are the key regional markets?
Which countries represent the most attractive single nucleotide polymorphism (SNP) genotyping market?
What is the breakup of the market based on the technology?
Which is the most attractive technology in the single nucleotide polymorphism (SNP) genotyping market?
What is the breakup of the market based on the application?
Which is the most attractive application in the single nucleotide polymorphism (SNP) genotyping market?
What is the competitive structure of the global single nucleotide polymorphism (SNP) genotyping market?
Who are the key players/companies in the global single nucleotide polymorphism (SNP) genotyping market?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Single Nucleotide Polymorphism (SNP) Genotyping Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technology
6.1 TaqMan SNP Genotyping
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Massarray SNP Genotyping
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 SNP GeneChip Arrays
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Application
7.1 Animal Genetics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Plant Improvement
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Diagnostic Research
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pharmaceuticals and Pharmacogenomics
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Agricultural Biotechnology
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
9.1 Overview
9.2 Drivers
9.3 Restraints
9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Agilent Technologies Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Eurofins Genomics (Eurofins Scientific SE)
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Illumina Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 LGC Limited
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 PREMIER Biosoft
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Promega Corporation
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 QIAGEN N.V
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Roche Holding AG
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.10 Thermo Fisher Scientific Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis

Figure 1: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Major Drivers and Challenges
Figure 2: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Technology (in %), 2022
Figure 5: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Application (in %), 2022
Figure 6: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Region (in %), 2022
Figure 7: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: China: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: China: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: India: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: India: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: France: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: France: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Country (in %), 2022
Figure 75: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Drivers, Restraints, and Opportunities
Figure 77: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Value Chain Analysis
Figure 78: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Porter's Five Forces Analysis

★調査レポート[一塩基多型（SNP）ジェノタイピングのグローバル市場：TaqManSNPジェノタイピング、MassarraySNPジェノタイピング、SNP遺伝子チップアレイ、その他] (コード：IMARC23JLY245)販売に関する免責事項を必ずご確認ください。
★調査レポート[一塩基多型（SNP）ジェノタイピングのグローバル市場：TaqManSNPジェノタイピング、MassarraySNPジェノタイピング、SNP遺伝子チップアレイ、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 細胞株同定試験の世界市場2023-2029：ショートタンデムリピート（STR）分析、 一塩基多型（SNP）分析、 その他
  • 世界の植物ジェノタイピング装置市場予測2023年-2028年
  • 世界のジェノタイピング市場予測2023年-2028年
  • インフルエンザワクチンの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 世界のモノクローナル抗体市場予測2022年-2028年
  • 世界の血液悪性腫瘍市場予測2023年-2028年

    • ◆H&Iグローバルリサーチのお客様（例）◆